By a.latrive, 3 December, 2020 IPRP - 6th Meeting - Public Statement The Management Committee (MC) of the International Pharmaceutical Regulators Programme (IPRP) held its sixth meeting on the 19th and 20th of November
By c.angulo, 7 August, 2020 Survey on Liposomes from Nanomedicines WG The NWG is conducting a Survey on Regulatory Requirements and Research Needs for Liposome Products amongst stakeholders, including Regulatory Agencies
By c.angulo, 22 July, 2020 Updated IDMP FAQ The Working Group on Identification of Medicinal Products (IDMP) has updated its Frequently Asked Questions (FAQ) document to address questions relate
By c.angulo, 11 June, 2020 IPRP - 5th Meeting - Public Statement The Management Committee (MC) of the International Pharmaceutical Regulators Programme (IPRP) held its fifth meeting on the 28th of May 2020. Represen
By c.angulo, 4 December, 2019 IPRP - 4th Meeting - Public Statement The fourth meeting of the International Pharmaceutical Regulators Programme (IPRP) Management Committee (MC) was held on the 20th and 21st of November
By c.angulo, 21 June, 2019 Outcome of WHO survey on reliance A focus topic of the IPRP MC meeting in Amsterdam, the Netherlands, on 2-3 June 2019, was reliance, the act by which one regulatory authority takes in